Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder

• Status: Completed
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether treating sleep difficulties in patients with seasonal affective disorder also improves their depressive symptoms.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lehigh Valley Hospital
• Collaborator: Takeda Pharmaceuticals North America, Inc.

Criteria

Inclusion Criteria:

• Male or female age 18-65 yrs.

• A diagnosis of seasonal affective disorder

• A Pittsburgh Sleep Quality Index >5

• English speaking

• Be able to sign informed consent

Exclusion Criteria:

• Active substance abuse

• Current psychotic symptoms

• Severe personality disorders

• Primary sleep disorders

• Severe chronic obstructive pulmonary disease (COPD)

• Prescription fluvoxamine(Luvox) use